The US Food and Drugs Administration’s (USFDA) grants orphan status to support development of medicines for the treatment of rare diseases that affect fewer than 2 lakh people in the US
Zydus receives orphan drug status for Sickle Cell Disease medication
📅 Published: February 6, 2026 |
📂 Category: Uncategorized